- Full Year 2023 Biomerieux SA Earnings Call TranscriptMar 14, 2024$108.55Earnings
- Q3 2023 Biomerieux SA Corporate Sales Call TranscriptOct 26, 2023
- Half Year 2023 Biomerieux SA Earnings Call TranscriptSep 01, 2023$104.25Earnings
- Biomerieux SA Evolution of Biomerieux's Governance Call TranscriptJun 14, 2023
- Q1 2023 Biomerieux SA Corporate Sales Call TranscriptApr 27, 2023
- Full Year 2022 Biomerieux SA Earnings Call TranscriptMar 08, 2023$95.68Earnings
- Q3 2022 Biomerieux SA Corporate Sales Call TranscriptOct 26, 2022
- Half Year 2022 Biomerieux SA Earnings Call TranscriptAug 31, 2022$91.9 (-10.53%)Earnings
- Q1 2022 Biomerieux SA Business Results Call TranscriptApr 12, 2022
- Full Year 2021 Biomerieux SA Earnings Call TranscriptMar 02, 2022$96.8 (-10.20%)Earnings
- Q3 2021 Biomerieux SA Business Review Call TranscriptOct 21, 2021
- Half Year 2021 Biomerieux SA Earnings Call TranscriptSep 01, 2021$124.65Earnings
- Q1 2021 Biomerieux SA Business Review TranscriptApr 27, 2021
- Full Year 2020 Biomerieux SA Earnings Call TranscriptFeb 24, 2021$132.88 (-0.09%)Earnings
- Q3 2020 Biomerieux SA Business Review Call TranscriptOct 22, 2020
- Half Year 2020 Biomerieux SA Earnings Call TranscriptSep 02, 2020$144.75 (-3.50%)Earnings
- Q1 2020 Biomerieux SA Corporate Sales Call TranscriptApr 16, 2020
- Full Year 2019 Biomerieux SA Earnings Call TranscriptFeb 26, 2020$94.71 (-3.60%)Earnings
- Q3 2019 Biomerieux SA Business Review Call TranscriptOct 22, 2019
- Half Year 2019 Biomerieux SA Earnings Call TranscriptSep 04, 2019$81.82 (+1.51%)Earnings
- Q1 2019 Biomerieux SA Corporate Sales Call TranscriptApr 24, 2019
- Full Year 2018 Biomerieux SA Earnings Call TranscriptFeb 27, 2019$82.8 (+4.28%)Earnings
Q1 2021 Biomerieux SA Business Review Transcript
Good day, and welcome to the bioMérieux First Quarter 2021 Business Review. Today's conference is being recorded. At this time, I would like to turn the conference over to Franck Admant. Please go ahead, sir.
©-
Thank you, Kim. Good afternoon, and thank you for joining us to review bioMérieux's performance for the first quarter of 2021. As usual, I am online with Alexandre Mérieux, Chairman and CEO; as well as Guillaume Bouhours, the CFO. Before handing the call over to Alexandre for preliminary remarks, please note that this conference call will include forward-looking statements.
I would like to remind you of the usual disclaimer saying that forward-looking statements are based entirely and partially on assessments or judgments that may change or be modified. Due to uncertainties and risks related to the company's environment, notably we described it in the 2020 registration document, including but not limited to, economic conditions, financial exposure to currency
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)